CX3CL1 and Parkinson disease: Interestingly, in this case, the administration of exogenous CX3CL1 directly into the substantia nigra caused microglial activation, dopaminergic cell depletion, and motor dysfunction, leading the authors to conclude that CX3CL1 could be responsible for some of the deleterious alterations commonly observed in Parkinson’s disease cases.